| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 105.321 | 238.128 | 246.398 | 389.680 | 409.373 | 511.456 | 614.698 |
| Total Income - EUR | - | - | - | 105.321 | 238.128 | 251.946 | 394.992 | 443.716 | 603.887 | 615.256 |
| Total Expenses - EUR | - | - | - | 103.576 | 195.452 | 231.598 | 353.710 | 373.967 | 525.705 | 532.715 |
| Gross Profit/Loss - EUR | - | - | - | 1.745 | 42.676 | 20.347 | 41.281 | 69.749 | 78.182 | 82.541 |
| Net Profit/Loss - EUR | - | - | - | 692 | 40.295 | 18.289 | 37.431 | 65.755 | 69.098 | 70.418 |
| Employees | - | - | - | 3 | 3 | 4 | 5 | 4 | 2 | 2 |
Check the financial reports for the company - Rampaclinic S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 16.230 | 22.983 | 162.303 | 212.092 | 228.794 | 842.679 | 897.368 |
| Current Assets | - | - | - | 22.671 | 113.928 | 88.823 | 76.632 | 37.044 | 36.373 | 54.349 |
| Inventories | - | - | - | 1.568 | 217 | 0 | 120 | 188 | 14.949 | 11.330 |
| Receivables | - | - | - | 1.749 | 63.676 | 13.906 | 7.963 | 25.364 | 15.616 | 32.799 |
| Cash | - | - | - | 19.355 | 50.035 | 74.917 | 68.549 | 11.492 | 5.808 | 10.220 |
| Shareholders Funds | - | - | - | 6.118 | 39.973 | 23.543 | 44.083 | 73.678 | 76.375 | 87.846 |
| Social Capital | - | - | - | 5.426 | 5.321 | 5.220 | 6.065 | 6.083 | 6.065 | 6.031 |
| Debts | - | - | - | 33.799 | 96.938 | 227.583 | 244.641 | 192.161 | 802.676 | 863.871 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Rampaclinic S.r.l.